• OPEN AN ACCOUNT
Indian Indices
Nifty
22,648.20 43.35
(0.19%)
Sensex
73,985.45 -625.66
( -0.84%)
Bank Nifty
49,231.05 -165.70
( -0.34%)
Nifty IT
33,203.35 2.40
( 0.01%)
Global Indices
Nasdaq
15,840.96 235.48
(1.51%)
Dow Jones
38,225.66 322.37
(0.85%)
Hang Seng
18,207.13 444.10
(2.50%)
Nikkei 225
38,236.07 -37.98
(-0.10%)
Forex
USD-INR
83.46 0.03
(0.03%)
EUR-INR
89.11 -0.30
(-0.33%)
GBP-INR
104.27 -0.36
(-0.34%)
JPY-INR
0.53 0.00
(-0.39%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Dr Reddys Laboratories Ltd
Dr. Reddy's launches condition management programme DailyBloom™ IBS
Apr 19,2024
Dr. Reddy's Laboratories announced the roll-out of its condition management programme DailyBloom™ IBS, India's first integrated care plan for Irritable Bowel Syndrome (IBS). The programme is based on extensive research and is enabled by a mobile application developed in-house. DailyBloom™ IBS focuses on a comprehensive care plan that includes diet management, psychological and physical wellness support for patients with IBS. Dr. Reddy's has launched the programme on ‘World IBS Day', a day that aims to increase awareness of the IBS condition, discuss misconceptions, challenges and even stigma attached to it.